南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

工程化机械敏感间充质干细胞(MSCs)能够实现针对不同类型肿瘤的合成放射治疗与诊断双重靶向治疗。

Engineered mechanosensitive MSCs enable synthetic radiotheranostic targeting across tumor types

Xiujie Yang, Qi Yin, Kui Li, Jianze Wang, Rui Song, Haoyi Zhou, Shu Han, Linyu Zhang, Yuwen Zeng, Da Xu, Feng Wang, Shixin Zhou, Yang Yang, Hua Zhu, Chunhong Zheng, Yang Li, Zhi Yang, Xing Yang, Zhao

Journal:Cell Stem Cell

IF:23.3

DOI:10.1016/j.stem.2026.07.015

PMID:42624106

Published:2026-08-20

research field:肿瘤学分子生物学细胞生物学

Abstract

Radiopharmaceutical-based imaging and targeted radionuclide therapy are often limited by heterogeneous or absent molecular targets in tumors. Here, we present a stiffness-responsive mesenchymal stem cell (MSC)-assisted relayed tumor-targeting (SMART) platform that converts matrix stiffness into a programmable molecular entry point for radiotheranostics. Engineered MSCs sense elevated mechanical stiffness within the tumor microenvironment and induce localized expression of synthetic biomarkers, thereby enabling radiopharmaceutical targeting independent of endogenous target availability. As a proof of concept, SMART-driven expression of prostate-specific membrane antigen (PSMA) enables sensitive tumor detection by 68 Ga-PSMA-617 positron emission tomography (PET) and effective treatment with 177 Lu-AB-PSMA-617 across multiple tumor models, with improved sensitivity and reduced off-target uptake compared with conventional 18 F-fluorodeoxyglucose PET. This platform is readily adaptable to alternative synthetic targets and induced pluripotent stem cell (iPSC)-derived MSCs. By translating a universal physical feature of tumors into an actionable molecular signature, SMART expands the scope of precision radiotheranostics beyond native biomarkers.

本文使用的Yeasen产品

购物车
客服
转染试用